EZH2 inhibtion and IFNy treatment of patient derived organoids [ChIP-seq]
We report the chromatin landscape of squamous lung cancer patient derived tumoroids treated with EZH2 inhibitor and IFNy Overall design: To determine chromatin peaks changed by EZH2 inhibition and IFNy upregulate at genes involved in antigen presentation machinery and immunogenicity